Insurers Remain Unfazed by Risks of Clinical Trials of COVID-19 Vaccine

The world is racing towards a vaccine in record time, stirring public concerns about safety to the extent that nine leading developers have felt compelled to issue a pledge to uphold scientific standards and testing rigor. Yet, while more than …

from News – Insurance Journal https://ift.tt/3dgUa8O